encouraging developments in triple negative breast cancer immunotherapy
Published 3 years ago • 1.2K plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
2:05
treatment advances in tnbc
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
0:41
recent advances in targeted therapies for tnbc
-
1:28
recent developments in treating tnbc with targeted therapies
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
11:53
new developments in triple-negative breast cancer therapies - medpage today
-
1:04
future directions in triple-negative breast cancer research
-
3:26
chemo-immunotherapy for tnbc
-
1:15
clinical implications of progress in tnbc therapies
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
2:05
immunotherapy in breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
1:01
chemo-immunotherapy for tnbc
-
1:00
overcoming challenges in treating patients with triple-negative breast cancer
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
1:15
challenges in tnbc
-
2:30
impassion130: immunotherapy for tnbc